What is Monopar Therapeutics's cash ratio?

Monopar Therapeutics (MNPR) reported cash ratio of 21.4× in Q1 2026.

What is the long-term trend for Monopar Therapeutics's cash ratio?

Over 5 years (2020 to 2025), Monopar Therapeutics's cash ratio has grown at a 9.9% compound annual growth rate (CAGR), from 14.1× to 22.6×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Monopar Therapeutics MNPR Cash ratio

Cash ratio at other companies

Bristol-Myers SquibbBMY

0.5×0.0×

Eli LillyLLY

0.1×0.0×

Bausch Health CompaniesBHC

0.3×0.0×

Ultragenyx PharmaceuticalRARE

0.5×+0.1×

Prime MedicinePRME

2.1×-0.9×

Wave Life SciencesWVE

10.9×+8.1×

Other financials

Income statement

See full

Revenue-—

Operating income-$5.2M-62.2%

Net income-$3.9M-48.3%

EPS (diluted)-$0.19—

Balance sheet

See full

Cash & equivalents$52.5M+32.3%

Total debt$230.4K+2,692%

Total equity$135.4M+153%

Total assets$138.0M+150%

Cash flow

See full

Operating cash flow-$3.5M+38.7%

Valuation

See full

Market cap$587.04M+192%

Enterprise value$534.72M+232%

Returns & leverage

See full

Return on equity-15.9%-6.6pp

Debt / equity0×0.0×

Current ratio56×—

Where this comes from

Calculated from Monopar Therapeutics’s reported figures.

cash and equivalents/total current liabilities=21.4×

Based on the most recent quarter.

The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monopar Therapeutics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monopar Therapeutics's cash ratio?: Monopar Therapeutics (MNPR) reported cash ratio of 21.4× in Q1 2026.
What is the long-term trend for Monopar Therapeutics's cash ratio?: Over 5 years (2020 to 2025), Monopar Therapeutics's cash ratio has grown at a 9.9% compound annual growth rate (CAGR), from 14.1× to 22.6×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.